Latest News for: retinitis

Edit

Retinitis Pigmentosa Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | SparingVision SAS, ...

GetNews 15 Apr 2025
The Key Retinitis Pigmentosa Companies in the market inlcude - SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc, Coave Therapeutics, jCyte, Nightstar Therapeutics, ReNeuron, and others.
Edit

Pykus Therapeutics Completes Trial Enrollment for PYK-2101, a Novel Retinal Sealant for the Treatment for ...

Longview News-Journal 10 Apr 2025
-- PYK-2101 eliminates 'face down positioning' after retinal surgery and is designed to improve visual and anatomical outcomes -- ....
Edit

Pykus Therapeutics Completes Trial Enrollment for PYK-2101, a Novel Retinal Sealant for the Treatment for Retinal Detachment

PR Newswire 10 Apr 2025
-- PYK-2101 eliminates 'face down positioning' after retinal surgery and is designed to improve visual and anatomical outcomes -- ... About PYK-2101. PYK-2101 is a patented, first-in-class biodegradable retinal hydrogel sealant.
Edit

The Retinols, Retinals, and AHAs We Use Every Day

New York Magazine 09 Apr 2025
4 items in this article 1 item on sale!. Tembe Denton-Hurst may never give up her AHA-retinoid blend from Skinbetter Science. Photo-Illustration. The Strategist; Photos. Tembe Denton-Hurst, Retailer ... Skinbetter Science AlphaRet Overnight Cream $145. $145.
Edit

Vision Veda – Plant-Based Eye Supplement for Blue Light Defense and Long-Term Retinal Health

Belleview Reporter 09 Apr 2025
The inclusion of Omega-3 Fatty Acids is crucial for maintaining retinal health and reducing inflammation, while Taurine helps protect against oxidative damage ... for optimal retinal health and function.
Edit

William Blair Initiates Coverage of Two Companies Developing Retinal Disease Therapies (William Blair & Company LLC)

Public Technologies 08 Apr 2025
(OCUL $6.36), both biotechnology companies developing therapies for the treatment of retinal vascular diseases ... Moreover, we believe the HEALIOS results support the best-in-class potential of Axpaxli across retinal vascular diseases.".
Edit

Retinal therapy may restore lost vision

Science Daily 03 Apr 2025
Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration ... .
Edit

RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa

PNAS 03 Apr 2025
... cause of inherited retinal degeneration is retinitis pigmentosa.
Edit

Stem Cell Discovery in Human Retina May Lead to Retinal Degeneration Treatments

The Scientist 03 Apr 2025
For individuals with inherited eye disorders such as retinitis pigmentosa or macular degeneration, the irreversible degeneration of the retina—a layer of photoreceptors at the back of the eye—can cause impaired vision and lead to blindness.
Edit

LUXTURNA Continues to Lead in Retinal Gene Therapy with Increased Market Penetration | DelveInsight

PR Newswire 26 Mar 2025
The therapy is administered as a single subretinal injection beneath the retina in patients with confirmed RPE65 mutations and viable retinal cells ... RPE65 inherited retinal dystrophies, including retinitis pigmentosa ... Retinitis Pigmentosa Market.
  • 1
×